Tag: Kidney Problems: Misc.
CKD Linked to Greater Neuromuscular Fatigability
Only peak force fatigability, but not peak rate of force development, contributed to fatigue variance
Dapagliflozin Reduces Hospitalizations Among Patients With CKD
Reduction seen in rate of admissions due to cardiac disorders, renal and urinary disorders, metabolism and nutrition disorders, neoplasms
Combination Treatment Beneficial in Albuminuric CKD
7.4 year gain in event-free survival for 50-year-old patients with combo therapy with ACEi/ARB and SGLT2 inhibitors
Symptom Burden Increases in Year Before Dialysis Initiation
Among older adults, symptom number and burden stabilized and decreased in the year after dialysis
Personalized Screening for Kidney Disease Evaluated in T1DM
Compared with annual screening for urinary albumin, personalized screening can reduce time spent with undetected albuminuria, testing frequency
ASN: Empagliflozin Cuts Risk for Progression in CKD
Risk for progression of kidney disease or death from cardiovascular causes reduced with empagliflozin versus placebo
ASN: Discontinuation of RAS Inhibitors Does Not Increase eGFR in CKD
No difference seen with discontinuation, continuation of RAS inhibitors among patients with advanced, progressive chronic kidney disease
CKD Incidence Differs by Race in People With Diabetes
Incidence lower in White patients versus Black, Hispanic, and indigenous populations
Second, Third COVID-19 Vaccine May Up Relapse in Glomerular Disease
Absolute increase in 30-day relapse risk associated with the second or third vaccine dose is small
